Mathew Robson

1.5k total citations
30 papers, 901 citations indexed

About

Mathew Robson is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Mathew Robson has authored 30 papers receiving a total of 901 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Oncology. Recurrent topics in Mathew Robson's work include Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (4 papers). Mathew Robson is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and CAR-T cell therapy research (4 papers). Mathew Robson collaborates with scholars based in United Kingdom, Australia and India. Mathew Robson's co-authors include R. Barbara Pedley, RB Pedley, Vineeth Rajkumar, Ethaar El‐Emir, Erik Årstad, Mark F. Lythgoe, Ran Yan, Uzma Qureshi, Berend Tolner and Kerry Chester and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Mathew Robson

30 papers receiving 889 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathew Robson United Kingdom 18 451 198 153 130 111 30 901
Paul J. Kleindl United States 14 378 0.8× 111 0.6× 214 1.4× 207 1.6× 60 0.5× 19 697
Hari Krishna R. Santhapuram United States 15 333 0.7× 129 0.7× 234 1.5× 222 1.7× 71 0.6× 21 694
Vessela Vassileva United Kingdom 14 404 0.9× 199 1.0× 466 3.0× 96 0.7× 120 1.1× 21 1.1k
Gang Ren China 20 288 0.6× 474 2.4× 270 1.8× 57 0.4× 124 1.1× 62 1.0k
Xiaoyang Zheng United States 11 472 1.0× 220 1.1× 151 1.0× 77 0.6× 87 0.8× 15 863
José M. Arencibia United States 21 582 1.3× 62 0.3× 262 1.7× 116 0.9× 32 0.3× 33 1.1k
Dong-Mei Feng United States 15 330 0.7× 71 0.4× 157 1.0× 119 0.9× 32 0.3× 18 773
Lynsey A. Huxham Canada 13 276 0.6× 100 0.5× 300 2.0× 61 0.5× 134 1.2× 15 806
Misu Lee South Korea 18 417 0.9× 129 0.7× 177 1.2× 44 0.3× 143 1.3× 59 961
Marco Ponassi Italy 24 765 1.7× 112 0.6× 167 1.1× 228 1.8× 40 0.4× 60 1.5k

Countries citing papers authored by Mathew Robson

Since Specialization
Citations

This map shows the geographic impact of Mathew Robson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathew Robson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathew Robson more than expected).

Fields of papers citing papers by Mathew Robson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathew Robson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathew Robson. The network helps show where Mathew Robson may publish in the future.

Co-authorship network of co-authors of Mathew Robson

This figure shows the co-authorship network connecting the top 25 collaborators of Mathew Robson. A scholar is included among the top collaborators of Mathew Robson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathew Robson. Mathew Robson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Robson, Mathew, Evangelia Kokalaki, Francesco Nannini, et al.. (2023). Enhancing CAR T-cell Therapy Using Fab-Based Constitutively Heterodimeric Cytokine Receptors. Cancer Immunology Research. 11(9). 1203–1221. 6 indexed citations
2.
Robson, Mathew, Christopher Allen, James Sillibourne, et al.. (2023). Novel Fas-TNFR chimeras that prevent Fas ligand-mediated kill and signal synergistically to enhance CAR T cell efficacy. Molecular Therapy — Nucleic Acids. 32. 603–621. 4 indexed citations
3.
Bulek, Anna, Mathew Robson, Evangelia Kokalaki, et al.. (2023). Exploration of T cell immune responses by expression of a dominant-negative SHP1 and SHP2. Frontiers in Immunology. 14. 1119350–1119350. 3 indexed citations
4.
Burrows, Natalie, Mathew Robson, Edoardo Gaude, et al.. (2016). Hypoxia-induced nitric oxide production and tumour perfusion is inhibited by pegylated arginine deiminase (ADI-PEG20). Scientific Reports. 6(1). 22950–22950. 30 indexed citations
5.
Johnson, Sean Peter, Rajiv Ramasawmy, Adrienne Campbell‐Washburn, et al.. (2016). Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling. British Journal of Cancer. 114(8). 897–904. 11 indexed citations
6.
Vassileva, Vessela, Vineeth Rajkumar, Mathew Robson, et al.. (2015). Significant Therapeutic Efficacy with Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer. Journal of Nuclear Medicine. 56(8). 1239–1245. 14 indexed citations
7.
Rajkumar, Vineeth, Vicky Goh, Muhammad Siddique, et al.. (2015). Texture analysis of 125I-A5B7 anti-CEA antibody SPECT differentiates metastatic colorectal cancer model phenotypes and anti-vascular therapy response. British Journal of Cancer. 112(12). 1882–1887. 19 indexed citations
8.
Galante, Eva, T. Okamura, Kerstin Sander, et al.. (2014). Development of Purine-Derived18F-Labeled Pro-drug Tracers for Imaging of MRP1 Activity with PET. Journal of Medicinal Chemistry. 57(3). 1023–1032. 11 indexed citations
9.
Funes, Juan M., Stephen Henderson, James M. Flanagan, et al.. (2014). Oncogenic transformation of mesenchymal stem cells decreases Nrf2 expression favoring in vivo tumor growth and poorer survival. Molecular Cancer. 13(1). 20–20. 31 indexed citations
10.
Pérez‐Medina, Carlos, et al.. (2013). Synthesis and evaluation of a 125I-labeled iminodihydroquinoline-derived tracer for imaging of voltage-gated sodium channels. Bioorganic & Medicinal Chemistry Letters. 23(18). 5170–5173. 7 indexed citations
11.
Pérez‐Medina, Carlos, et al.. (2012). Evaluation of a 125I-labelled benzazepinone derived voltage-gated sodium channel blocker for imaging with SPECT. Organic & Biomolecular Chemistry. 10(47). 9474–9474. 5 indexed citations
13.
Yang, Jun, Oliver Staples, Luke W. Thomas, et al.. (2012). Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression. Journal of Clinical Investigation. 122(2). 600–611. 77 indexed citations
14.
Yan, Ran, Ethaar El‐Emir, Vineeth Rajkumar, et al.. (2011). One‐Pot Synthesis of an 125I‐Labeled Trifunctional Reagent for Multiscale Imaging with Optical and Nuclear Techniques. Angewandte Chemie International Edition. 50(30). 6793–6795. 30 indexed citations
15.
Panasyuk, Ganna, Ivan Nemazanyy, Valeriy Filonenko, et al.. (2009). mTORβ Splicing Isoform Promotes Cell Proliferation and Tumorigenesis. Journal of Biological Chemistry. 284(45). 30807–30814. 35 indexed citations
16.
Allan, Charles M., Patrick Lim, Mathew Robson, Jenny Spaliviero, & David J. Handelsman. (2009). Transgenic mutant D567G but not wild-type human FSH receptor overexpression provides FSH-independent and promiscuous glycoprotein hormone Sertoli cell signaling. American Journal of Physiology-Endocrinology and Metabolism. 296(5). E1022–E1028. 19 indexed citations
17.
Beverdam, Annemiek, Terje Svingen, Stefan Bagheri‐Fam, et al.. (2008). Sox9 -dependent expression of Gstm6 in Sertoli cells during testis development in mice. Reproduction. 137(3). 481–486. 11 indexed citations
18.
El‐Emir, Ethaar, Jason L.J. Dearling, Alexandra Huhalov, et al.. (2007). Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models. British Journal of Cancer. 96(12). 1862–1870. 25 indexed citations
19.
Kogelberg, Heide, Berend Tolner, Surinder K. Sharma, et al.. (2006). Clearance mechanism of a mannosylated antibody–enzyme fusion protein used in experimental cancer therapy. Glycobiology. 17(1). 36–45. 47 indexed citations
20.
Neoptolemos, John P., G D Oates, K. M. Newbold, et al.. (1995). Cyclin/proliferation cell nuclear antigen immunohistochemistry does not improve the prognostic power of Dukes' or Jass' classifications for colorectal cancer. British journal of surgery. 82(2). 184–187. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026